Pharmasaga Co. Ltd., a drug discovery and development company, focuses on developing anti-diabetic drugs. It develops Pdia4 inhibitors, which includes PS-001 for type 2 diabetes; and PS-002 for type 1 diabetes. The company was founded in 2021 and is based in Taipei, Taiwan.